Need Help?

UK10K_RARE_SIR

In the UK10K project we propose a series of complementary genetic approaches to find new low frequency/rare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage), and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes.Our studies will focus primarily on cardiovascular-related quantitative traits, obesity and related metabolic traits, neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples, and also use imputation down to 0.1% allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs, and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches.The SIR (Severe Insulin Resistance) samples are part of the “rare disease” group, and will undergo exome sequencing. For further information with regard to this cohort please contact Robert Semple (rks16@cam.ac.uk).

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001000153 Illumina Genome Analyzer II Illumina HiSeq 2000 38
EGAD00001000188 Illumina Genome Analyzer II Illumina HiSeq 2000 63
EGAD00001000218 Illumina Genome Analyzer II Illumina HiSeq 2000 81
EGAD00001000334 Illumina Genome Analyzer II Illumina HiSeq 2000 111
EGAD00001000419 Illumina Genome Analyzer II Illumina HiSeq 2000 121
EGAD00001000757 Illumina HiSeq 2000 2
Publications Citations
The UK10K project identifies rare variants in health and disease.
Nature 526: 2015 82-90
601
Assessing the role of rare genetic variants in drug-resistant, non-lesional focal epilepsy.
Ann Clin Transl Neurol 8: 2021 1376-1387
6